Deletion of ER-retention Motif on SARS-CoV-2 Spike Protein Reduces Cell Hybrid During Cell-cell Fusion

The novel SARS-CoV-2 has rapidly develop into a world pandemic for the reason that first reported case in December 2019,…

Continue Reading →

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

 A number of energetic vaccination approaches have confirmed ineffective in lowering the substantial morbidity and mortality attributable to respiratory syncytial virus (RSV)…

Continue Reading →